EC releases assessment of EMA and EBA host applications
On 30 September 2017, the European Commission (EC) published its assessment of the 27 offers received by Member States to host the European Banking Authority (EBA) and the European Medicines Agency (EMA), which are both currently located in the United Kingdom and will have to be relocated once the UK leaves the EU.
The criteria for this assessment had been set out by EC President Juncker and Council President Tusk and had been endorsed by the Heads of State and Government of the EU27 at the European Council (Article 50 format) on 22 June 2017. The assessment is fully based on the information sent by the Member States and provides (1) Individual assessment summaries for each of the 27 offers; (2) a general assessment summary providing an overview of all offers, allowing for comparisons to be made more easily; and (3) 27 assessment grids providing more detailed information on specific issues. It respects the Member States' decision that the criteria should be unweighted and does not provide a ranking or shortlist of any kind. The Agencies have also been consulted in the process. Austria has submitted applications for hosting both EMA and EBA.
The European Medicines Agency (EMA) plays an essential role in protecting human and animal health in the EU, by evaluating and supervising human and veterinary medicinal products in the Single Market. While it does not conduct research itself, it evaluates new medicines before they are authorised in the European Union and monitors their safety. It also stimulates research and innovation by giving scientific advice and guidance to developers of medicines.
On the basis of the Commission's assessment, the Council will have a political discussion at the General Affairs Council (Article 50 format) in October 2017. A final decision will be taken at the General Affairs Council (Article 50 format) in November 2017.
For more information: